In a 2025 observational cohort, the Risk of Vestibular Disorders with Semaglutide and Tirzepatide study reported dizziness in 18% of semaglutide users compared with 10% in the control group, indicating a higher-than-baseline incidence and reinforcing the need to monitor for dose- or timing-related patterns
CFTX-1554 is a novel inhibitor targeting the GPCR family member Angiotensin II type 2 receptor (AT2R)
[15] Any persistent or severe vomiting or diarrhoea should be reported to the clinical trial team promptly
Choosing local, traditional, and properly processed foods supports long-term health
I train providers across the country on testosterone, peptides, and GLP-1s
PlexusDx pricing transparencyat $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutidemakes it simple to budget FSA allocation in advance